Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation

Non-alcoholic steatohepatitis (NASH) is a progressive, chronic, liver disease whose prevalence is growing worldwide. Despite several agents being under development for treating NASH, there are no drugs currently approved. The Farnesoid-x-receptor (FXR) and the G-protein coupled bile acid receptor 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Carino, Adriana, Marchianò, Silvia, Biagioli, Michele, Fiorucci, Chiara, Zampella, Angela, Monti, Maria Chiara, Morretta, Elva, Bordoni, Martina, Di Giorgio, Cristina, Roselli, Rosalinda, Ricci, Patrizia, Distrutti, Eleonora, Fiorucci, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567134/
https://www.ncbi.nlm.nih.gov/pubmed/31117231
http://dx.doi.org/10.3390/nu11051132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567134/
https://www.ncbi.nlm.nih.gov/pubmed/31117231
http://dx.doi.org/10.3390/nu11051132

Ejemplares similares